This announcement is a separate document:
东方金诚国际信用评估有限公司关于灵康药业集团股份有限公司2023年半年度业绩预告及实控人拟减持公司股份的关注公告
Announcement of Dongfang Jincheng International Credit Evaluation Co., Ltd. on the 2023 semi-annual performance forecast of Lingkang Pharmaceutical Group Co., Ltd. and concerns about the actual controller\'s proposed reduction in the company\'s shares
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated